HomeABUS • NASDAQ
add
Arbutus Biopharma Corp
$3.08
Makalipas ang Oras ng Trabaho:(0.00%)0.00
$3.08
Sarado: May 16, 4:02:40 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$3.12
Sakop ng araw
$3.05 - $3.15
Sakop ng taon
$2.71 - $4.72
Market cap
589.90M USD
Average na Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.76M | 15.14% |
Gastos sa pagpapatakbo | 5.83M | 9.79% |
Net na kita | -24.53M | -37.21% |
Net profit margin | -1.39K | -19.16% |
Kita sa bawat share | -0.18 | -32.01% |
EBITDA | -12.70M | 32.56% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 112.71M | -12.79% |
Kabuuang asset | 117.01M | -22.14% |
Kabuuang sagutin | 37.85M | 6.17% |
Kabuuang equity | 79.16M | — |
Natitirang share | 191.53M | — |
Presyo para makapag-book | 7.61 | — |
Return on assets | -26.19% | — |
Return on capital | -34.60% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -24.53M | -37.21% |
Cash mula sa mga operasyon | -13.39M | 30.60% |
Cash mula sa pag-invest | 11.35M | -2.95% |
Cash mula sa financing | 2.78M | -88.60% |
Net change in cash | 746.00K | -95.56% |
Malayang cash flow | 59.62K | 100.47% |
Tungkol
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Itinatag
2007
Headquarters
Website
Mga Empleyado
44
